Notably, TMZ + Bev suppressed tumor growth only in the IDH1-mutant U87 xenograft, whereas neither TMZ nor Bev monotherapy inhibited tumor growth in either cell type and IDH1-wiltype tumors did not respond to Bev + TMZ (Figure 6). The gene discussed is IDH1; the disease is neoplasm.